Mitochondria-derived reactive oxygen species induce over-differentiation of neural stem/progenitor cells after non-cytotoxic cisplatin exposure

Even at subtherapeutic levels, cisplatin disrupts NSPC integrity, driving differentiation through mitochondrial ROS-dependent mechanisms. While inhibiting ROS reduced differentiation, it did not restore NSPC proliferation. These findings highlight the vulnerability of NSPCs to cisplatin, even at doses considered safe. The metabolic shift toward mitochondrial respiration may contribute to this differentiation bias. Future research on co-administration of antioxidant agents during chemotherapy could protect NSPC integrity and mitigate developmental and cognitive risks, especially in neonates exposed via breastfeeding.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2025-04-29
DOI
https://doi.org/10.3389/fcell.2025.1555153
Citations
6
Primary Topic
Neurogenesis and neuroplasticity mechanisms
Type
article
Field-Weighted Citation Impact
7.91

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mitochondria-derived reactive oxygen species induce over-differentiation of neural stem/progenitor cells after non-cytotoxic cisplatin exposure

Claudia Altamirano, Felipe A. Bustamante-Barrientos, María Jesús Araya, Noymar Luque‐Campos et al.
6 citations
Frontiers in Cell and Developmental Biology
Neurogenesis and neuroplasticity mechanisms
7.91
article

Mitochondria-derived reactive oxygen species induce over-differentiation of neural stem/progenitor cells after non-cytotoxic cisplatin exposure

Claudia Altamirano, Felipe A. Bustamante-Barrientos, María Jesús Araya, Noymar Luque‐Campos, Eduardo Silva-Pavez, Ana María Vega-Letter, Eliana Lara-Barba, Patricia Luz‐Crawford, Yeimi Herrera-Luna, Liliana Yantén-Fuentes, Jonathan Morales-Reyes, Cynthia García-Guerrero
article en
6 citations

Abstract

Even at subtherapeutic levels, cisplatin disrupts NSPC integrity, driving differentiation through mitochondrial ROS-dependent mechanisms. While inhibiting ROS reduced differentiation, it did not restore NSPC proliferation. These findings highlight the vulnerability of NSPCs to cisplatin, even at doses considered safe. The metabolic shift toward mitochondrial respiration may contribute to this differentiation bias. Future research on co-administration of antioxidant agents during chemotherapy could protect NSPC integrity and mitigate developmental and cognitive risks, especially in neonates exposed via breastfeeding.

Frontiers in Cell and Developmental BiologyVol. 13
Pontificia Universidad Católica de Valparaíso (CL), Universidad de Los Andes, Chile (CL), San Sebastián University (CL)
Fondo Nacional de Desarrollo Científico y Tecnológico
Openalex Percentile: Top 3%
Neurogenesis and neuroplasticity mechanisms
7.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mitochondria-derived reactive oxygen species induce over-differentiation of neural stem/progenitor cells after non-cytotoxic cisplatin exposure — Claudia Altamirano, Felipe A. Bustamante-Barrientos, et al. · Frontiers in Cell and Developmental Biology (2025) | TGRS Research Map | TGRS